|[September 27, 2016]
1st Detect, an Astrotech Subsidiary, Strengthens IP Portfolio
1st Detect Corporation, a subsidiary of Astrotech Corporation
(NASDAQ: ASTC), announced the United States Patent and Trademark Office
(USPTO) issued a key patent for increasing the performance of the
company's unique ion trap mass spectrometer used for chemical analysis
and detection. 1st Detect's total patent count is now 17 U.S.
and 6 international issued, and 7 U.S. and 10 international pending.
"This patented technology enables 1st Detect to analyze
without sample preparation at high levels of sensitivity and speed, and
opens new markets," said Thomas B. Pickens III, CEO of 1st
Detect. "Some potential applications include breath analysis, explosives
detection, chemical warfare agent detection and detection of
various trace impurities in a sample."
U.S. Patent No. 9,451,364, entitled "Preconcentrating a Sample in a
Preconcentrator Evacuated to Substantially the Same Pressure as an
Analytical Device," represents a key technological advantage for 1st
Detect to miniaturize mass spectrometers yet retain the ability to
analyze a wide variety of compounds at extremely low concentrations, in
under a minute.
1st Detect's preconcentrator is an inlet to its mass
spectrometer, used to concentrate the chemical signal in order to lower
the limit of detection for trace chemical signals. This patent protects
the technique and design aspect of using evacuation of a preconcentrator
tube in order to bridge the vacuum barrier into a mass spectrometer,
increasing concentration efficiency.
1st Detect Corporation has developed an instrument that
revolutionizes the chemical detection and analysis market by delivering
laboratory performance mass spectrometry in a small, affordable and
portable package. The 1st Detect chemical analyzer utilizes
core technology that is fast, highly sensitive and accurate. The unit is
capable of detecting a wide variety of chemicals including residues and
vapors from explosives, chemical warfare agents, toxic chemicals, food
and beverage contaminants, and pollutants. These capabilities, combined
in an economically priced solution, make it an ideal tool for a variety
of aplications in the research, security, industrial, process flow and
About 1st Detect Corporation
1st Detect, a subsidiary of Astrotech Corporation (NASDAQ:
ASTC), develops, manufactures, and sells powerful, highly sensitive, and
accurate mass spectrometers that are used in explosive and chemical
warfare detection for the Department of Homeland Security and the
military. The 1st Detect technology can also be used in
various medical and industrial applications including breath analysis,
leak detection and food and beverage manufacturing. These capabilities,
combined in an economically priced, transportable, and ruggedized
solution, make it an ideal tool for a variety of applications. For more
information on 1st Detect Corporation, please visit www.1stDetect.com.
About Astrotech Corporation
Astrotech Corporation (NASDAQ: ASTC) is an innovative science and
technology company that invents, acquires, and commercializes
technological innovations sourced from research institutions,
laboratories, universities, and internally, and then funds, manages, and
builds proprietary, scalable start-up companies for profitable
divestiture to market leaders to maximize shareholder value. Sourced
from Oak Ridge Laboratory's chemical analyzer research, 1st
Detect develops, manufactures, and sells powerful, highly sensitive,
and accurate mass spectrometers that can be used in explosive and
chemical warfare detection for the Department of Homeland Security and
the military. Sourced from decades of image research from the
laboratories of IBM and Kodak (News - Alert) combined with classified satellite
technology from government laboratories, Astral Images sells film
to digital image enhancement, defect removal and color correction
software, and post processing services providing economically feasible
conversion of television and feature 35mm and 16mm films to the new 4K
ultra-high definition (UHD), high-dynamic range (HDR (News - Alert)) format necessary
for the new generation of digital distribution. Sourced from NASA's
extensive microgravity research, Astrogenetix is applying a
fast-track on-orbit discovery platform using the International Space
Station to develop vaccines and other therapeutics. Demonstrating its
entrepreneurial strategy, Astrotech management sold its state-of-the-art
satellite servicing operations to Lockheed Martin (News - Alert) in August 2014.
Astrotech has operations throughout Texas and is headquartered in
Austin. For information, please visit www.astrotechcorp.com.
This press release contains forward-looking statements that are made
pursuant to the Safe Harbor provisions of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements are
subject to risks, trends, and uncertainties that could cause actual
results to be materially different from the forward-looking statement.
These factors include, but are not limited to, whether we can
successfully develop our proprietary technologies and whether the market
will accept our products and services, as well as other risk factors and
business considerations described in the Company's Securities and
Exchange Commission filings including the annual report on Form 10-K.
Any forward-looking statements in this document should be evaluated in
light of these important risk factors. The Company assumes no obligation
to update these forward-looking statements.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160927005540/en/
[ Back To TMCnet.com's Homepage ]